2019
DOI: 10.1002/jbmr.3887
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Estrogen Replacement on Bone Geometry and Microarchitecture in Adolescent and Young Adult Oligoamenorrheic Athletes: A Randomized Trial

Abstract: Oligoamenorrheic athletes (OAs) have lower bone mineral density (BMD) and greater impairment of bone microarchitecture, and therefore higher fracture rates compared to eumenorrheic athletes. Although improvements in areal BMD (aBMD; measured by dual-energy X-ray absorptiometry) in OAs have been demonstrated with transdermal estrogen treatment, effects of such treatment on bone microarchitecture are unknown. Here we explore effects of transdermal versus oral estrogen versus no estrogen on bone microarchitecture… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
16
0

Year Published

2020
2020
2025
2025

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 61 publications
(17 citation statements)
references
References 79 publications
(168 reference statements)
1
16
0
Order By: Relevance
“…( 58 ) Young oligomenorrheic athletes who received transdermal estradiol increased trabecular number over 12 months of training to a greater extent than those who received a COCP, providing some support for the role of estradiol in trabecular microarchitecture adaptations to mechanical loading in young women; however, there were no differences between the estradiol patch and no treatment. ( 59 ) Although low estradiol is a plausible mechanism to explain differences in trabecular adaptation, P1NP, and sclerostin between groups, there was no difference in estradiol between contraceptive groups (Gifford et al, unpublished data). We did not, however, standardize measurements around the menstrual cycle or contraceptive use, or measure ethinyl estradiol.…”
Section: Discussionmentioning
confidence: 99%
“…( 58 ) Young oligomenorrheic athletes who received transdermal estradiol increased trabecular number over 12 months of training to a greater extent than those who received a COCP, providing some support for the role of estradiol in trabecular microarchitecture adaptations to mechanical loading in young women; however, there were no differences between the estradiol patch and no treatment. ( 59 ) Although low estradiol is a plausible mechanism to explain differences in trabecular adaptation, P1NP, and sclerostin between groups, there was no difference in estradiol between contraceptive groups (Gifford et al, unpublished data). We did not, however, standardize measurements around the menstrual cycle or contraceptive use, or measure ethinyl estradiol.…”
Section: Discussionmentioning
confidence: 99%
“…2 Under conditions of negative energy balance, the physiological process of growth and reproduction are directly affected, as evidenced by the suppressed metabolism and the consequential decrement in metabolic hormones such as the thyroid hormones, insulin-like growth factor-1, and insulin. 4 In exercising women, persistent energy deficiency can lead to the development of menstrual disturbances, 5 where the independent 6 and combined effects of energy and estrogen deficiency result in detrimental impacts to bone strength and quality, [7][8][9] known as the Female Athlete Triad (Triad). 10,11 Additional factors which may contribute the development of energy deficiency and downstream physiological consequences include participation in leanness or aesthetic sports, [12][13][14] disordered eating behaviors (ie, increased drive for thinness 15,16 and increased dietary cognitive restraint 17,18 ), and clinical eating disorders.…”
Section: Introductionmentioning
confidence: 99%
“…Crucially, there were no significant differences in weight or menstrual function change between the patch and pill groups by the end of the study, that could have confounded these results. Microarchitectural indices also improved significantly in the patch versus COCP group, especially at the tibia ( 107 ). These aforementioned findings in oligo-amenorrhoeic athletes are mirrored in females with AN.…”
Section: Treatmentmentioning
confidence: 92%